Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress towards a new tuberculosis vaccine.

D B Lowrie1, C L Silva, R E Tascon

  • 1National Institute for Medical Research, London, England. d-lowrie@nimr.mrc.ac.uk

Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|November 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum: Centrality-Dependent Modification of Jet-Production Rates in Deuteron-Gold Collisions at sqrt[s_{NN}]=200  GeV [Phys. Rev. Lett. 116, 122301 (2016)].

Physical review letters·2025
Same author

Disentangling Centrality Bias and Final-State Effects in the Production of High-p_{T} Neutral Pions Using Direct Photon in d+Au Collisions at sqrt[s_{NN}]=200  GeV.

Physical review letters·2025
Same author

On the origin of low-valent uranium oxidation state.

Nature communications·2024
Same author

Measurement of Direct-Photon Cross Section and Double-Helicity Asymmetry at sqrt[s]=510  GeV in p[over →]+p[over →] Collisions.

Physical review letters·2023
Same author

Accumulation and decomposition of cultural residues of Theobroma grandiflorum, Paullinia cupana, Bixa orellana and forest in the southern region of Amazonas.

Brazilian journal of biology = Revista brasleira de biologia·2023
Same author

Probing Gluon Spin-Momentum Correlations in Transversely Polarized Protons through Midrapidity Isolated Direct Photons in p^{↑}+p Collisions at sqrt[s]=200  GeV.

Physical review letters·2021

Developing a new tuberculosis vaccine is a simpler goal than new drugs due to resistance concerns. Research shows protein antigens administered via DNA vaccines can induce protective immunity against tuberculosis.

Area of Science:

  • Immunology
  • Microbiology
  • Vaccinology

Background:

  • Tuberculosis (TB) requires new treatments, including drugs and vaccines, to combat drug resistance.
  • Developing new anti-TB drugs is challenging due to emerging resistance, necessitating combination therapies.
  • An effective TB vaccine offers a promising alternative, potentially overcoming resistance issues with multiple antigenic targets.

Purpose of the Study:

  • To explore the potential of novel vaccine strategies against tuberculosis.
  • To identify protective antigens and evaluate vaccine delivery methods for inducing cell-mediated immunity.

Main Methods:

  • Investigated protein antigens administered with adjuvants or as DNA vaccines in animal models.
  • Assessed protective immunity by measuring accelerated bacterial multiplication arrest and sustained decline.

Related Experiment Videos

  • Utilized adoptive transfer of T cells to demonstrate the role of cytotoxic T cells in protection.

    • Main Results:

    • Diverse protein antigens, including secreted and stress proteins (e.g., Ag85, ESAT-6), induced high levels of protective immunity in animal models.
    • Protection involved antigen-specific cytotoxic T cells producing interferon-gamma and lysing infected macrophages.
    • DNA vaccination demonstrated superiority over recombinant vectors for inducing protective immunity.

    Conclusions:

    • Novel TB vaccines targeting diverse antigens, particularly through DNA vaccination, show significant promise.
    • Cell-mediated immunity, driven by cytotoxic T cells, is crucial for protection against tuberculosis.
    • Further research into TB vaccine development is warranted, focusing on antigens produced by actively multiplying and growth-inhibited bacteria.